When to recommend a sentinel node biopsy in melanoma

Melanoma Insights for Professionals

Sentinel node biopsy (SNB) plays a key role in assessing the prognosis of melanomas.

In this fireside chat from our new SNB Training Program (Sentinel Node Biopsy: From guidelines to practice), MIA’s Prof Georgina Long AO, Prof John Thompson AO and A/Prof Sydney Ch’ng discuss:

• the history of SNB in the management of melanoma
• its current role in the stratification of patients into those who may benefit from adjuvant therapies verses those for whom active surveillance is more appropriate
• other potential benefits of SNB, including the likelihood of SNB itself reducing the risk of nodal recurrence.

This podcast is suitable for Surgeons, Medical Oncologists, General Practitioners and other healthcare professionals.

SPEAKERS

• A/Prof Sydney Ch’ng - Plastic & Reconstructive Surgeon and Head & Neck Surgeon, Melanoma Institute Australia | Associate Professor of Surgery, The University of Sydney
• Prof Georgina Long AO - Co-Medical Director, Melanoma Institute Australia | Chair, Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia and Royal North Shore Hospital, The University of Sydney
• Prof John Thompson AO - Emeritus Professor of Melanoma and Surgical Oncology, The University of Sydney | Senior Surgeon, Melanoma Institute Australia

Please note that this podcast was accurate at the time of recording (July 2022) but may not reflect the rapidly evolving treatment landscape and approvals in Australia.